Cargando…
Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are clonal hematological disorders arising from hematopoietic stem cells that have accumulated various genetic abnormalities. MDS are heterogeneous in nature but uniformly characterized by chronic and progressive cytopenia from ineffective hematopoiesis, dysplasia in...
Autor principal: | Nakajima, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835461/ https://www.ncbi.nlm.nih.gov/pubmed/32009100 http://dx.doi.org/10.2169/internalmedicine.4214-19 |
Ejemplares similares
-
Molecular Pathogenesis of Myelodysplastic Syndromes
por: Visconte, Valeria, et al.
Publicado: (2014) -
Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease
por: Visconte, Valeria, et al.
Publicado: (2014) -
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies
por: Harada, Hironori, et al.
Publicado: (2015) -
Decitabine in the treatment of myelodysplastic syndromes
por: Saba, Hussain I
Publicado: (2007) -
New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)